UROGEN PHARMA - 48 Year Dividend Yield History | URGN

Historical dividend payout and yield for UROGEN PHARMA (URGN) since 1971. The current TTM dividend payout for UROGEN PHARMA (URGN) as of February 15, 2019 is $0.00. The current dividend yield for UROGEN PHARMA as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.557B $0.008B
UroGen Pharma Ltd. is a clinical stage biopharmaceutical company. It focused on developing urological pathologies with a focus on uro-oncology. The company's product candidates include MitoGel and VesiGel which are in clinical trial stage. Its platform technologies include: RTGel and Immunotherapy. UroGen Pharma Ltd. is based in Ra'anana, Israel.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.167B 12.95
Gilead Sciences (GILD) United States $85.858B 10.77
Bio-Techne Corp (TECH) United States $7.121B 47.98